Propylthiouracil-induced	propylthiouracil-induced	O	O
perinuclear-staining	perinuclear-staining	O	O
antineutrophil	antineutrophil	B_chemicals	O
cytoplasmic	cytoplasmic	I_chemicals	O
autoantibody-positive	autoantibody-positive	O	O
vasculitis	vasculitis	O	S_disease
in	in	O	O
conjunction	conjunction	O	O
with	with	O	O
pericarditis	pericarditis	O	O
.	.	O	O

OBJECTIVE	objective	O	O
:	:	O	O
To	to	O	O
describe	describe	O	O
a	a	O	O
case	case	O	O
of	of	O	O
propylthiouracil-induced	propylthiouracil-induced	O	O
vasculitis	vasculitis	O	S_disease
manifesting	manifesting	O	O
with	with	O	O
pericarditis	pericarditis	O	O
.	.	O	O

METHODS	methods	O	O
:	:	O	O
We	we	O	O
present	present	O	O
the	the	O	O
first	first	O	O
case	case	O	O
report	report	O	O
of	of	O	O
a	a	O	O
woman	woman	O	O
with	with	O	O
hyperthyroidism	hyperthyroidism	O	S_disease
treated	treated	O	O
with	with	O	O
propylthiouracil	propylthiouracil	S_chemicals	O
in	in	O	O
whom	whom	O	O
a	a	O	O
syndrome	syndrome	O	S_disease
of	of	O	O
pericarditis	pericarditis	O	O
,	,	O	O
fever	fever	O	S_disease
,	,	O	O
and	and	O	O
glomerulonephritis	glomerulonephritis	O	S_disease
developed	developed	O	O
.	.	O	O

Serologic	serologic	O	O
testing	testing	O	O
and	and	O	O
immunologic	immunologic	O	O
studies	studies	O	O
were	were	O	O
done	done	O	O
,	,	O	O
and	and	O	O
a	a	O	O
pericardial	pericardial	O	O
biopsy	biopsy	O	O
was	was	O	O
performed	performed	O	O
.	.	O	O

RESULTS	results	O	O
:	:	O	O
A	a	O	O
25-year-old	25-year-old	O	O
woman	woman	O	O
with	with	O	O
Graves	graves	O	B_disease
'	'	O	I_disease
disease	disease	O	S_disease
had	had	O	O
a	a	O	O
febrile	febrile	O	O
illness	illness	O	O
and	and	O	O
evidence	evidence	O	O
of	of	O	O
pericarditis	pericarditis	O	O
,	,	O	O
which	which	O	O
was	was	O	O
confirmed	confirmed	O	O
by	by	O	O
biopsy	biopsy	O	O
.	.	O	O

Serologic	serologic	O	O
evaluation	evaluation	O	O
revealed	revealed	O	O
the	the	O	O
presence	presence	O	O
of	of	O	O
perinuclear-staining	perinuclear-staining	O	O
antineutrophil	antineutrophil	B_chemicals	O
cytoplasmic	cytoplasmic	I_chemicals	O
autoantibodies	autoantibodies	S_chemicals	O
(	(	O	O
pANCA	panca	O	O
)	)	O	O
against	against	O	O
myeloperoxidase	myeloperoxidase	S_chemicals	O
(	(	O	O
MPO	mpo	O	O
)	)	O	O
.	.	O	O

Propylthiouracil	propylthiouracil	S_chemicals	O
therapy	therapy	O	O
was	was	O	O
withdrawn	withdrawn	O	O
,	,	O	O
and	and	O	O
she	she	O	O
was	was	O	O
treated	treated	O	O
with	with	O	O
a	a	O	O
1-month	1-month	O	O
course	course	O	O
of	of	O	O
prednisone	prednisone	S_chemicals	O
,	,	O	O
which	which	O	O
alleviated	alleviated	O	O
her	her	S_chemicals	O
symptoms	symptoms	O	O
.	.	O	O

A	a	O	O
literature	literature	O	O
review	review	O	O
revealed	revealed	O	O
no	no	O	O
prior	prior	O	O
reports	reports	O	O
of	of	O	O
pericarditis	pericarditis	O	O
in	in	O	O
anti-MPO	anti-mpo	O	O
pANCA-positive	panca-positive	O	O
vasculitis	vasculitis	O	S_disease
associated	associated	O	O
with	with	O	O
propylthio-	propylthio-	O	O
uracil	uracil	O	O
therapy	therapy	O	O
.	.	O	O

CONCLUSION	conclusion	O	O
:	:	O	O
Pericarditis	pericarditis	O	O
may	may	O	O
be	be	O	O
the	the	O	O
initial	initial	O	O
manifestation	manifestation	O	O
of	of	O	O
drug-induced	drug-induced	O	S_disease
vasculitis	vasculitis	O	S_disease
attributable	attributable	O	O
to	to	O	O
propylthio-	propylthio-	O	O
uracil	uracil	O	O
therapy	therapy	O	O
.	.	O	O

